BRÈVE publiée le 27/06/2024 à 19:01, il y a 2 mois 23 jours Fuller, Smith & Turner PLC Announces Share Buyback London Stock Exchange Ordinary Shares Share Buyback Transparency Rules Fuller's
BRÈVE publiée le 27/06/2024 à 19:01, il y a 2 mois 23 jours Fuller, Smith & Turner PLC annonce le rachat d'actions Rachat D'actions Actions Ordinaires Bourse De Londres Règles De Transparence Fuller
COMMUNIQUÉ DE PRESSE publié le 27/06/2024 à 18:56, il y a 2 mois 23 jours Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces the purchase of 10,000 'A' ordinary shares as part of its share buyback programme, with an average price of 689.0248 GBp per share Voting Rights London Stock Exchange Share Buyback Programme Numis Securities Limited Fuller Smith Turner PLC
BRÈVE publiée le 26/06/2024 à 18:05, il y a 2 mois 24 jours Fuller, Smith & Turner PLC : Transaction sur actions propres Actions Propres Rachat D'actions Bourse De Londres Règles De Transparence Fuller
BRÈVE publiée le 26/06/2024 à 18:05, il y a 2 mois 24 jours Fuller, Smith & Turner PLC: Transaction in Own Shares London Stock Exchange Share Buyback Treasury Shares Transparency Rules Fuller’s
COMMUNIQUÉ DE PRESSE publié le 26/06/2024 à 18:00, il y a 2 mois 24 jours Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces the purchase of 11,324 'A' ordinary shares at an average price of 695.5284 GBp each through Numis Securities Limited Voting Rights London Stock Exchange Fuller, Smith & Turner PLC Share Buyback Programme Numis Securities Limited
BRÈVE publiée le 24/06/2024 à 18:45, il y a 2 mois 26 jours Fuller, Smith & Turner PLC: Transaction in Own Shares London Stock Exchange Share Buyback Treasury Shares Disclosure And Transparency Rules Fuller, Smith & Turner
BRÈVE publiée le 24/06/2024 à 18:45, il y a 2 mois 26 jours Fuller, Smith & Turner PLC : Transaction sur actions propres Actions Propres Rachat D'actions Bourse De Londres Fuller, Smith Et Turner Règles D'information Et De Transparence
COMMUNIQUÉ DE PRESSE publié le 24/06/2024 à 18:40, il y a 2 mois 26 jours Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces purchase of 50,000 'A' ordinary shares at an average price of 700.00 GBp each as part of share buyback program Voting Rights London Stock Exchange Share Buyback Numis Securities Limited Fuller Smith Turner PLC
BRÈVE publiée le 21/06/2024 à 18:39, il y a 2 mois 29 jours Fuller, Smith & Turner PLC: Transaction in Own Shares London Stock Exchange Share Buyback Treasury Shares FCA Disclosure Fuller, Smith & Turner
Publié le 20/09/2024 à 17:40, il y a 14 heures 55 minutes Availability of the 2024 Half-Year Financial Report
Publié le 20/09/2024 à 17:40, il y a 14 heures 55 minutes Mise à disposition du Rapport Financier Semestriel 2024
Publié le 20/09/2024 à 23:40, il y a 8 heures 55 minutes Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024
Publié le 20/09/2024 à 23:30, il y a 9 heures 5 minutes Final Bell Holdings International Ltd. Announces Sale of Final Bell Corp.
Publié le 20/09/2024 à 23:00, il y a 9 heures 35 minutes AI/ML Innovations Inc. Provides Second Status Update
Publié le 20/09/2024 à 22:30, il y a 10 heures 5 minutes Electric Metals Announces Changes to its Board of Directors
Publié le 20/09/2024 à 22:15, il y a 10 heures 20 minutes Torq Clarifies Finder’s Warrant Exercise Price of $0.10 Financing
Publié le 20/09/2024 à 22:58, il y a 9 heures 36 minutes Freelance.com: Mise à disposition du Document d’Enregistrement Universel 2023
Publié le 20/09/2024 à 21:00, il y a 11 heures 35 minutes Aurubis celebrates ribbon-cutting at the first multimetal recycling plant in the United States
Publié le 20/09/2024 à 20:14, il y a 12 heures 20 minutes EQS-Adhoc: GRAMMER AG sells TMD Group in North America
Publié le 20/09/2024 à 19:50, il y a 12 heures 45 minutes BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator
Publié le 20/09/2024 à 19:47, il y a 12 heures 48 minutes EQS-Adhoc: BRAIN Biotech AG concludes royalty monetization deal for up to EUR 128.88 million on investigational pharma compound deucrictibant with Royalty Pharma